NJK14047

CAS No. 1800576-41-3

NJK14047( NJK 14047 )

Catalog No. M12739 CAS No. 1800576-41-3

NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NJK14047
  • Note
    Research use only, not for human use.
  • Brief Description
    NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.
  • Description
    NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α, suppresses RSV and influenza A virus replication by inhibiting virus-induced p38 MAPK activation; inhibits RSV- and influenza A-mediated p38 MAPK activation in epithelial cells, decreases viral replication and viral mRNA synthesis; also displays significant anti-HBV activity, efficiently suppresses the secretion of HBV antigens and HBV particles from HBV genome-transfected cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NJK 14047
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1800576-41-3
  • Formula Weight
    445.515
  • Molecular Formula
    C27H27NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C=C(C=C1)C(=O)NC2CC2)C3=CC=C(C=C3)C(=O)C4=CC=C(C=C4)OCC(CO)O
  • Chemical Name
    N-cyclopropyl-4'-(4-(2,3-dihydroxypropoxy)benzoyl)-6-methyl-[1,1'-biphenyl]-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kim SY, et al. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00214-17. 2. Choi MS, et al. Biochem Biophys Res Commun. 2016 Aug 26;477(3):311-6. 3. Heo J, et al. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3694-8.
molnova catalog
related products
  • PAF (C16)

    PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.

  • p38α inhibitor 1

    p38α inhibitor 1 is an inhibitor of p38α .

  • APS6-45

    APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity.